Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-24

Clinical Trial Update: Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aspirin for prevention of collapse in osteonecrosis of the hip is ongoing or status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Osteonecrosis of Femoral Head, Osteonecrosis; Aseptic, Idiopathic | Phase 3 | Status: UNKNOWN